Companies /Healthcare

908 Devices Inc

NASDAQ: MASS Medical Devices
$9.37
▼ $0.15 (−1.58%) today
Markets closed · 5:04pm ET

MASS at a Glance

Valuation
Market cap
$390.5M
Profitability
Revenue (TTM)
$65.8M
Profit margin
-36.9%
EPS (TTM)
$-0.63
Price
52-week range
$5 – $13
Street target
$14.00

Headquartered in Burlington, MA Fiscal year ends December NASDAQ: MASS 908devices.com

About 908 Devices

908 Devices Inc. (Nasdaq: MASS) designs and manufactures purpose-built handheld chemical analysis devices used at the point of need to identify unknown and invisible materials.

Its tools serve health, safety and defense tech applications, including:
- addressing the fentanyl and illicit drug crisis
- toxic carcinogen exposure
- global security threats

The products combine complementary analytical technologies, including an FTIR (Fourier-transform infrared) portfolio, with software automation and machine learning.

The company earns product revenue from device sales and service and contract revenue. Recurring revenue was 27% of the total in Q3 2026. Its installed base was 4,409 devices as of Q3 2026.

In 2026 it acquired NIRLab, a connected near-infrared drug-checking platform intended to expand recurring revenue. The company holds roughly $99 million in cash, cash equivalents and marketable securities and has no debt. Updated

Latest Activity

MASS908 Devices
Q3 2026
EPS
-$0.11
est -$0.10-4.8%
Revenue
$19M
est $18M+3.5%

Revenue rose 35% year over year on record 308 device placements and the first full quarter of NIRLab, exceeding expectations even with a penny-level EPS miss. Management raised the low end of full-year revenue guidance to $68.5 million to $70.0 million.

Quarterly EPS — reported vs estimate

MASS Coverage

Frequently Asked Questions

What does 908 Devices do?

908 Devices Inc. (Nasdaq: MASS) designs and manufactures purpose-built handheld chemical analysis devices used at the point of need to identify unknown and invisible materials.

What is the MASS stock price target?

The Wall Street consensus 12-month price target for MASS is $14.00.